SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Tempus Extends AstraZeneca Services Pact With $200 Million Five-Year Commitment

AstraZeneca committed to $200 million in fees to Tempus during a renewed five-year term, according to an 8-K filing.

TEMAZN

Related stories